Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of PF-07209960 in advanced or metastatic solid tumors was terminated, with results posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Carcinoma
• Renal Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck
• Urothelial Carcinoma

Drugs mentioned

• PF-07209960 (PF-07209960)

Snippet

Sponsor: Pfizer | Conditions: Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: TERMINATED | Results posted: 2024-07-29